Compare NGSX to:
After Hours:
7.4985
-0.00 (-0.02%) 4:11pm ET
| Last Trade: | 7.50 |
|---|---|
| Trade Time: | 4:00pm ET |
| Change: | |
| Prev Close: | 7.42 |
| Open: | 7.41 |
| Bid: | 6.75 x 100 |
| Ask: | 8.67 x 100 |
| 1y Target Est: | 11.00 |
| Day's Range: | 7.26 - 7.63 |
|---|---|
| 52wk Range: | 0.89 - 9.20 |
| Volume: | 132,638 |
| Avg Vol (3m): | 103,942 |
| Market Cap: | 132.33M |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.23 |
| Div & Yield: | N/A (N/A) |
| Tue, Nov 24 | NeurogesX to Present at Piper Jaffray Health Care ConferencePR Newswire |
| Tue, Nov 24 | NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board DirectorPR Newswire |
| Tue, Nov 17 | [$$] Pacific Sunwear and Sunpower Fallat The Wall Street Journal Online |
| Tue, Nov 17 | NEUROGESX INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online |
| Tue, Nov 17 | NeurogesX shares rise following FDA approvalAP |
| Tue, Nov 17 | Early-Market Movers: Semitool, Cerusat Fox Business |
| Tue, Nov 17 | NeurogesX to Hold Conference Call to Discuss FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)PR Newswire |
| Mon, Nov 16 | NeurogesX wins FDA OK for pain treatment Qutenzaat MarketWatch |
| Mon, Nov 16 | Fda Approves Qutenza(TM), First and Only Prescription Strength Capsaicin Product for Pain ReductionPR Newswire |
| Mon, Nov 16 | NeurogesX pain patch gets FDA OKat bizjournals.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.